baber/WOPTO huggingface dataset:
Patent CA-2451107-A1 (CA)
Title: Multifunction peripheral devices
Inventor: CONLEY MICHAEL
IPC: G06F3/12
Filed: 2001-11-26
Abstract: In a system for dynamically and remotely providing user interface (UI) displ ay and processing information to a touch panel embedded within a multifunction peripheral (MFP) such as a digital copier having an internal computer for controlling the touch panel, a method that comprises linking the internal computer to an external data communication network having an external remote computer on the network; and upon the inputting of desired selections by a user at the UI and communicating the same over the network to the external computer, providing information from the external computer via the network back to the internal computer that enables dynamically changing or updating the UI display and behavior during run time of the MFP.
Patent CA-2451657-A1 (CA)
Title: Fly ash composition for use in concrete mix
Inventor: STYRON ROBERT WILLIAM
IPC: C04B22/10
Filed: 2002-06-24
Abstract: A fly ash composition is provided which includes a blend of Class C fly ash, potassium carbonate, and lithium carbonate, which, in combination, reduce alkali silica reactivity when the fly ash composition is used in concrete applications. The fly ash composition includes from about 65 to 99 wt.% Class C fly ash, from about 0.1 wt.% to about 4 wt% potassium carbonate, and from about 0.1 wt.% to about 4 wt.% lithium carbonate.
Patent CA-2453031-A1 (CA)
Inventor: BRUST CLIFFORD S
IPC: G06T15/10
Filed: 2002-07-03
Abstract: A synthetic rendering of the terrain within a selected field of view is created from raw terrain elevation data, and the resolution of the rendering is proportioned to the altitude above ground level (altitude AGL) of the aircraft. All the data points are subdivided into tiles. Only data from tiles within a prescribed field of view are considered for processing; all others are ignored. Within the selected tiles, only some of the terrain elevation data points are passed to the graphics processor for rendering. At maximum resolution, when the aircraft is on the ground or at a low altitude, there are relatively fewer tiles within the field of view and the fraction of the data points from each tile within the field of view passed for rendering is relatively large. As the aircraft's altitude AGL level increases, the field of view also increases in area increasing the number of tiles within the field of view. However, the number of data points forwarded for rendering by the graphics processor is kept approximately constant by selecting progressively fewer and fewer terrain elevation data points from each tile for rendering as altitude AGL increases. Only the data points that lie within tiles inside a prescribed field of view are forwarded to the graphics processor for rendering. Once the tiles have been selected, the terrain elevation data points are grouped in groups of a size that depends on altitude AGL, with more terrain data points in the grouped as attitude increases. Preferably the groups are triangle strips. Only the highest elevation from each group is passed to the graphics processor for rendering.
Patent CA-2454514-A1 (CA)
Inventor: HUNG TAK
IPC: A61K31/7088
Filed: 2002-08-02
Abstract: L'invention concerne des gènes humains de la sphingosine kinase (SPHK) qui sont identifiés en tant que modulateurs de la voie de passage p53, et qui sont donc des cibles thérapeutiques destinées à des troubles liés à une fonction p53 déficiente. Cette invention a aussi trait à des méthodes d'identification des modulateurs de p53 consistant à cribler des agents qui modulent l'activité de SPHK.
Patent CA-2455987-A1 (CA)
Title: Tetrahydroindolone and purine derivatives linked to arylpiperazines
Inventor: FOREMAN MARK M
IPC: A61K47/44
Filed: 2002-07-30
Abstract: Pharmaceutical composite compositions comprising tetrahydroindolones linked to arylpiperazines and derivatives thereof are disclosed. Specifically, composi te compositions useful in treating anti-psychotic disorders are disclosed. The composite compositions disclosed herein can effectively ameliorate symptoms and treat psychotic disorders without causing a decrease in cognitive function. Generally, the composite compounds consist of two moieties, moiety A and B in which a tetrahydroindolone comprises a moiety A linked through a linker L to a moiety B, where B is an arylpiperazinyl moiety. The composite compound provides anti-psychotic actively by interaction with GABA, seratoninne and dopamine receptors. The composite molecules with the combine d activities will provide treat psychiatric and neurological diseases without cognitive impairment.
Patent CA-2457029-A1 (CA)
Title: Breath freshening film
Inventor: XU GUOFENG
IPC: A61K8/00
Filed: 2002-08-19
Abstract: A rapidly dissolvable orally consumable film composition for delivering breath freshening agents to the oral cavity wherein the composition is formed from a homogeneous mixture of a water soluble, low viscosity hydroxyalkylmethyl cellulose and a water dispersible starch and a flavoring agent.
Patent CA-2459829-A1 (CA)
Inventor: FISHLER EYAL
IPC: H04L12/56
Filed: 2002-08-22
Abstract: A system (10) and method for an improved two-way packet-centric like radio communication network that transmits signals and data over Internet protocol.  The improved like radio communications network provides advanced features and enhanced services to its users, such as the capability of roaming across a plurality of similar like radio communications networks. A plurality of client devices (12, 14, 16) including an enhanced client application for the operation of two-way like radio networks that accesses, contacts, and communicates with one or more client devices of the same network or one or more client devices of different like radio networks (36, 40).
Patent CA-2463420-A1 (CA)
Inventor: PUSKAS ROBERT S
IPC: C12Q1/68
Filed: 2002-10-24
Abstract: The present invention provides methods for determining genetic haplotype comprising identifying target nucleic acids or gene fragments, said nucleic acids or gene fragments comprising a haplotype of interest, and detecting at least one parameter displayed by one of a primer-dependent transcript, a probe, or a primer-dependent transcript/probe complex. Further provided are methods for determining genetic haplotype comprising labeling nucleic acids or gene fragments with a least one probe, and detecting the velocity of the nucleic acid molecule or gene fragment by sequentially measuring at least on e parameter displayed by the probes.
Patent CA-2469158-A1 (CA)
Inventor: BYRNE MICHAEL ANTHONY
IPC: B21D28/14
Filed: 2001-12-12
Abstract: A die assembly (10) including a base (12), an adjustable post (16), and an impacting post (56). The adjustable post (16) is slidably coupled to the bas e (12) and movable between first and second cutting positions to cut different ly sized items. The impacting post (56) is movable between an impact position proximate the adjustable post (16) and a removed position displaced from the adjustable post (16).
Patent CA-2473469-A1 (CA)
Title: Tolerogenic peptides from myelin basic protein
Inventor: STREETER HEATHER BARBARA
IPC: A61P25/00
Filed: 2003-01-30
Abstract: There is provided a peptide which is capable of binding to an MHC class I or II molecule without further processing (i.e. an apitope) which comprises a portion of the region (131-158) of myelin basic protein, in particular there is provided an apitope which is selected from the following myelin basic protein peptides: (134-148, 135-149, 136-150, 137-151, 138-152, 139-153, 140- 154). There is also provided the use of such a peptide in a pharmaceutical composition and a method to treat and/or prevent a disease using such a peptide.
Patent CA-2474502-A1 (CA)
Title: Distortion reduction calibration
Inventor: SHAH PETER JIVAN
IPC: H04B1/30
Filed: 2003-02-03
Abstract: Techniques are disclosed for compensating for second-order distortion in a wireless communication device. In a zero-intermediate frequency (IF) or low-IF  architecture, IM2 distortion generated by the mixer (20) results in undesirable distortion levels in the baseband output signal. A compensation circuit (104) provides a measure of the IM2 distortion current independent of the radio frequency (RF) pathway to generate an IM2 calibration current. The IM2 calibration current is combined with the baseband output signal to thereby eliminate the IM2 currents generated within the RF pathway. In one embodiment, the calibration is provided at the factory during final testing. In alternative embodiment, additional circuitry (156, 158) may be added to the wireless communication device to provide a pathway between the transmitter (150) and the receiver (146). The transmitter signal is provided to the receiver to permit automatic calibration of the unit. An internal signal source (162) may be used in place of the transmitter (150). The auto-calibration may be performed to eliminate IM2 distortion or permit optimization of the circuit to minimize other forms of distortion or interference.
Patent CA-2477379-A1 (CA)
Inventor: GRAVESTOCK MICHAEL BARRY
IPC: A61K31/5377
Filed: 2003-02-25
Abstract: La présente invention a trait à des composés chimiques de formule (I), ou un sel pharmaceutiquement acceptable, ou un ester hydrolysable in vivo de ceux-ci, formule dans laquelle : N-HET est, par exemple, de formule (Ic) ou (If), dans lesquelles R1 est, par exemple, halogène ou un groupe alkyle en C¿1?-C¿4? qui est substitué par un substituant choisi parmi, par exemple, un groupe hydroxy, alcoxy en C¿1?-C¿4?, amino, cyano ou azido ; Q est choisi parmi, par exemple, la formule Q1 dans laquelle R?2¿ et R?3¿ sont indépendamment hydrogène ou fluoro ; T est choisi d'une gamme de groupes, par exemple, de formule (TC12b), dans laquelle m est 0, 1 ou 2. Lesdits composés sont utiles en tant qu'agents antibactériens. L'invention a trait également à des procédés pour la fabrication desdits composés et des compositions pharmaceutiques les contenant.
Patent CA-2479467-A1 (CA)
Inventor: BAN VLADIMIR SINISA
IPC: G02B6/42
Filed: 2003-03-17
Abstract: L'invention concerne des appareils à fibres optiques comportant des éléments à réseau de Bragg de volume (VBG). Un appareil à fibre optique peut comporter une ou plusieurs entrées optiques, un ou plusieurs éléments VBG, et un ou plusieurs récepteurs optiques. L'invention concerne également des procédés de fabrication d'éléments VBG et de commande de la réponse de filtre. L'invention concerne par ailleurs une puce VBG ainsi qu'un appareil à fibres optiques comportant une telle puce. Ladite puce comporte une structure en verre monolithique recevant une pluralité de VBG.
Patent CA-2480221-A1 (CA)
Inventor: LI SONGHUA
IPC: A61K36/575
Filed: 2002-04-15
Abstract: Technical Field: A therapeutic cream for dermatitis. Technical Problems: To provide a therapeutic cream efficacious for atopic dermatitis. Means for Resolution: Having a composition of 3% of Sophora radix, 2% of Curcuma aromatisca, 2% of Magnoliae cortex, 2% of Montan cortex, 1% of Baphicacanthe s cusia, 1% of Borneolum syntheticum, 2% of Scutellariae radix, 2% of Phellodendri cortex, 1% of Angellica dahurica, 3% of lemon, 2% of Polygonum cuspidatum, 0.5% of Glycyrrhizae radix, 0.5% of Chidii rhizoma, 0.5% of Angelica acutiloba, 0.5% of salicylic acid, 0.5% of resorcin, 3% of lanoline , 3% of alcohol and 70.5% of white petrolactum. Owing to synergistic action of the antibacterial, antiviral, antiallergic, antiinflammtory, blood circulati on- accelerating, antifungal, sterilizing and antipruritic effects of the above- described components, the effect of accelerating the penetration of active ingredients into the deep part under the skin of Chidii rhizoma and Angelica acutiloba, and the cornificaiton-accelerating effects of salicylic acid and resorcin, various dermatites such as atopic dermatitis can be innovatively treated. Major use: To be used in treating dermatitis, in particular, atopic dermatitis.
Patent CA-2481212-A1 (CA)
Title: Composition and method for organ preservation
Inventor: TASHIRO YASUHITO
IPC: A01N1/02
Filed: 2003-03-28
Abstract: The present invention relates to a composition for organ preservation, comprising an inulin type fructan as an active ingredient. The composition for organ preservation can suppress the hypofunction of an organ and damage to a histological structure and can improve the state of preservation of the organ in the course of organ transplantation and the like.
Patent CA-2481391-A1 (CA)
Title: Preventives/remedies for hotflash
Inventor: KUSAKA MASAMI
IPC: C07D487/04
Filed: 2003-04-10
Abstract: It is intended to provide preventives/remedies for hotflash which contain a nonpeptidic compound having an antagonism to gonatropin-releasing hormone, in particular, a nonpeptidic compound showing migration into the brain and having antagonism to gonatropin-releasing hormone.
Patent CA-2482539-A1 (CA)
Inventor: POOLE DAVID L
IPC: B41J35/28
Filed: 2003-01-10
Abstract: A ribbon cartridge for a thermal transfer printer is configured to provide a retractable feed for a donor ribbon (16) wound on a core (44) within the housing (46), and a clutch (48) operatively coupled to the core. A resilient structure (68, 70) is coupled to the clutch (48) and to the cartridge housin g (46) such that the release of energy stored in the resilient structure (68, 70) by advance of the donor ribbon produces retraction of ribbon slack, if t he donor ribbon (16) is released or backfed. Alternatively, a ribbon roll (42) having a self-contained clutching and slack take-up capability includes a hollow core (44) configured to receive a roll of ribbon (42) and a clutch having a friction component configured to induce frictional engagement with the core (44). At least one end (72, 74) of the clutch is adapted to be externally constrained, and a resilient component (68, 70) is located betwee n the friction component (66) and at least one end (72, 74) of the clutch.</SD OAB>
Patent CA-2484040-A1 (CA)
Title: Palette de carton ondule
Inventor: HORIUCHI YASUHIKO
IPC: B65D19/00
Filed: 2003-05-26
Abstract: L'invention a trait à une palette en carton ondulé, qui permet d'éviter la rupture des poutrelles sous l'effet de l'effondrement de pièces de renforcement de liaison, et ce même en cas de mouvement latéral lors du transport par un véhicule de transport. Des plaques-plancher (18 et 19) sont collées aux surfaces aussi bien supérieure qu'inférieure de la pluralité des poutrelles (1), lesquelles sont formées par le maintien, dans un tube de forme carrée, d'éléments (2) possédant des parties de tube carrées (3 et 4), ces dernières partageant une plaque de base (5) et possédant des plaques internes (8) qui se chevauchent sous l'action de la paire de pièces de renforcement de liaison (21). Lesdites pièces de renforcement de liaison (21) sont dotées de dimensions telles que les deux bords latéraux de ces dernières peuvent venir buter contre les plaques externes (6) des deux parties de tube carrées, et des pièces pliées vers l'intérieur (11 et 12) sont reliées de manière continue avec les parties d'extrémité des plaques externes (6) des deux parties de tube carrées. Etant donné que les côtés aussi bien supérieur qu'inférieur des pièces pliées vers l'intérieur (11 et 12) peuvent venir buter contre la plaque de base (5) ou les plaques supérieures (7) correspondantes des parties de tube carrées à l'état plié vers l'intérieur, et que les pièces pliées vers l'intérieur (11 et 12) font obstacle aux pièces pliées vers l'intérieur (12 et 11) concourantes, il est possible de maintenir l'état plié desdites pièces.
Patent CA-2485184-A1 (CA)
Inventor: LI XIANG
IPC: C12Q1/68
Filed: 2003-05-23
Abstract: L'invention concerne un procédé d'identification de gènes impliqués dans le processus NF-kB, caractérisé en ce qu'il comprend les étapes suivantes : détermination du niveau d'expression d'un gène dans un échantillon expérimental obtenu sur des cellules à niveaux déficients de composants du processus NF-kB ; détermination du niveau d'expression dudit gène dans un échantillon témoin obtenu sur des cellules de type sauvage à niveaux de composants d'un processus biologique ; sélection de gènes ayant un niveau d'expression, modulés dans ledit échantillon expérimental, par rapport audit échantillon de type sauvage. L'invention concerne également un procédé de traitement de maladies à caractère inflammatoire par modulation de l'activité de IKK.alpha..
Patent CA-2485297-A1 (CA)
Inventor: BOEHM FRANK H JR
IPC: A61M5/19
Filed: 2003-05-12
Abstract: Publié sans précis
Patent CA-2485371-A1 (CA)
Title: Inhaler
Inventor: ESSER RALF
IPC: A61M16/10
Filed: 2002-05-13
Abstract: The invention relates to an inhaler comprising a catalytic burner and a fuel tank (6) containing hydrogen that is connected to said burner, a container (15) for inhalation additives such as aromatic substances and/or active ingredients, at least one inlet (2) for a gaseous mixture containing oxygen, in particular for air and an outlet (3) for an inhalation mixture containing aromatic substances and/or active ingredients.
Patent CA-2487805-A1 (CA)
Inventor: SILVA DOMINGOS J
IPC: C07D471/04
Filed: 2003-05-30
Abstract: L'invention concerne de nouveaux inhibiteurs de PDF et de nouvelles méthodes d'utilisation desdits inhibiteurs.
Patent CA-2488367-A1 (CA)
Title: Antiallergic agents
Inventor: ITAI AKIKO
IPC: A61K31/137
Filed: 2003-06-05
Abstract: A medicine for the prevention of and/or treatments for allergic diseases and/or endometriosis and/or uterus myoma, which contains as an active ingredient a substance selected from the group consisting of a compound represented by the general formula (I): (I) (wherein X represents a connecting group in which the main chain has 2 to 5 atoms; A represents hydrogen, etc.; E  represents optionally substituted aryl; and ring Z represents, e.g., arene which may have one or more substituents besides the groups represented by the formulae -O-A and -X-E), a pharmacologically acceptable salt of the compound, hydrates of these, and solvates of these.
Patent CA-2488855-A1 (CA)
Title: Antigen-presenting cells for neuroprotection and nerve regeneration
Inventor: COHEN AVRAHAM
IPC: C12N5/0793
Filed: 2003-06-12
Abstract: Pharmaceutical compositions and methods for preventing or inhibiting neurona l degeneration, or for promoting nerve regeneration, in the central nervous system (CNS) or peripheral nervous system (PNS), in the treatment of an injury, disorder or disease of the CNS or PNS, comprise antigen-presenting cells, preferably dendritic cells, that have been pulsed with an agent selected from the group consisting of: (a) a nervous system (NS)-specific antigen or an analog thereof; (b) a peptide derived from an NS-specific antigen or from an analog thereof, or an analog or derivative of said peptid e; (c) a copolymer selected from the group consisting of Copolymer 1, a Copolym er 1-related peptide or polypeptide, and poly-Glu50 Tyr50; and (d) a non-self antigen.
Patent CA-2490371-A1 (CA)
Inventor: GAGNON MARC
IPC: H04B1/04
Filed: 2003-06-26
Abstract: A communications system in which a plurality of transmitter and receiver stations, wherein the transmitter stations are co-located in the same geographic area and capable of communication with each other and an improved method of Automatic Transmitter Power Control (ATPC) operation, wherein the method allows only one transmitter to engage in ATPC at a time per channel s et and another improved method of ATPC in which there exists at least two co- located transmitters capable of ATPC operation and wherein the transmitters share transmitter ATPC status.
Patent CA-2490807-A1 (CA)
Title: System for efficiently covering a sectorized cell utilizing beam forming and sweeping
Inventor: GOLDBERG STEVEN JEFFREY
IPC: H04B7/26
Filed: 2003-06-20
Abstract: A communication system transmits and receives communications (Fig. 3) within a sectorized cell between at least one primary station (PS) and at least one secondary station. The communication system includes a unit for generating and shaping a beam (B); an antenna for transmitting and receiving signals within said beam (B); and a unit for directing the beam. The shaped beam is directed at a plurality of predetermined directions; either continuously or discretely.
Patent CA-2491918-A1 (CA)
Title: Methods for detecting or assaying virus
Inventor: AOYAGI KATSUMI
IPC: C09K23/00
Filed: 1998-08-04
Abstract: A method for treating a hepatitis C or hepatitis B virus-containing sample, characterized by treatment of the virus-containing sample with a treatment solution containing (1) an anionic surfactant and (2) an amphoteric surfactant, nonionic surfactant or protein denaturant, and a virus assay method using said treating method. Also provided is a method for treating a hepatitis C virus-containing sample, characterized by treatment of the virus-containing sample with a treatment solution containing (1) a chaotropic ion and (2) an acidifying agent, and a virus assay method using said treating method. Further provided is a hepatitis C virus assay method comprising treating a hepatitis C virus antigen-containing sample with a surfactant having an alkyl group of or more carbon atoms and a secondary, tertiary or quaternary amine, or a nonionic surfactant, or of both of them, and measuring binding of the antigen with a hepatitis C virus antibody. Finally, there is also provided a monoclonal antibody and a hybridoma producing the same for carrying out the above methods.
Patent CA-2493454-A1 (CA)
Inventor: DONG ZHIMING
IPC: C07H19/056
Filed: 2003-08-05
Abstract: Nouveau procédé de production d'un intermédiaire de lévovirine de la formule (IV). La lévovirine est un antiviral nucléosidique.
Patent CA-2494609-A1 (CA)
Title: Optical structures including polyurea
Inventor: MULLEN PATRICK W
IPC: G02B5/02
Filed: 2003-08-04
Abstract: Optical structures and sheeting that include polyurea and method for forming same are proposed in accordance with aspects of the present invention. One and two-component layers can be used to form the optical structures. The optical structures can include microstructures formed from polyurea. The sheeting can include at least one of cube-corner prisms, open-faced cube-corner prisms, linear prisms, lenticular lenses, moth-eye structures, lenses, Fresnel lens arrays, lenses, and fish-eye lens arrays.
Patent CA-2496300-A1 (CA)
Inventor: SCHOPFER CHRISTEL RENATE
IPC: C12N9/02
Filed: 2003-07-30
Abstract: L'invention concerne des procédés pour l'expression transgénique ciblée de séquences d'acide nucléique dans une fleur végétale, ainsi que des cassettes d'expression transgénique et des vecteurs d'expression transgénique comportant des promoteurs dotés d'une spécificité d'expression pour la fleur végétale. La présente invention porte également sur des organismes transformés (de préférence des plantes) au moyen de ces cassettes d'expression transgénique ou de ces vecteurs d'expression transgénique, des cultures issues de ces organismes, des éléments ou des produits de multiplications issus de ces organismes. Enfin, l'invention concerne aussi l'utilisation de ces substances pour fabriquer des aliments pour les humains et les animaux, des semences, des produits pharmaceutiques ou des produits de chimie fine.
Patent CA-2497960-A1 (CA)
Title: Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
Inventor: CERAMI ANTHONY
IPC: A61K47/48
Filed: 2003-09-09
Abstract: Methods for increasing the hematocrit of an individual while maintaining the tissue protective activities of endogenous through the administration of a pharmaceutical compound containing chemically modified long acting erythropoietin. Also disclosed are the new chemically modified long acting erythropoietins, methods of producing the chemically modified long acting erythropoietins, and compositions comprising the chemically modified long acting erythropoietins.
Patent CA-2498428-A1 (CA)
Inventor: FOUGERE ROBERT VINCENT
IPC: G01D21/00
Filed: 2005-01-19
Abstract: The invention generally relates to a measuring devices for measuring the various movements and specifically the vertical movement and horizontal movements within an integral locking device used for intermodal containers.